ScienceEU-Startupsabout 2 hours ago
En Carta raises €5M for at-home tests
4 min read
En Carta Diagnostics raised €5 million in a first closing to bring at-home molecular tests for Lyme disease and STIs to market. The round includes €3 million in equity led by Blue Forest Ventures and €2 million in non-dilutive financing from Bpifrance.
Level
Hype check
Tap to vote and see what everyone thinks.
